Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 120
Infectious Diseases Drugs 90
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 60
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 44
Drug Discovery 42
Diabetes Drugs 42
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 38
Clinical Trials 36
Urological Disorders Drugs 35
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 27
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 24
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Surgical Procedures 20
Stem Cells 19
Oncology 19
Analgesics 18
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Infusions and Injectables 13
Diagnostics 13
Medical Devices 13
Bladder Cancer Drugs 12
Drug Delivery 12
Dermatology 11
Healthcare Services 9
Respiratory Drugs 9
Pharmaceutical Manufacturing 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Needles and Syringes 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,136 Results (Page 48 of 57)
- Relevance
  Sort by

Immuno-Oncology Drugs Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

Viral and Non-Viral Vector Manufacturing Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

Penile Cancer Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

Soft Tissue Sarcoma Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

Human DNA Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
111 Pages
Global

From

€3500EUR$4,314USD£3,153GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Preventive Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
95 Pages
Global

From

€3500EUR$4,314USD£3,153GBP

Theranostics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

Musculoskeletal Disorders Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
August 2024
113 Pages
Global

From

€3500EUR$4,314USD£3,153GBP

Bone Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

Top 20 Vaccine Companies In-Depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

 Report
April 2020
165 Pages
Global

From

€1208EUR$1,390USD£1,051GBP

Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034

 Report
April 2024
287 Pages
Global

From

€6909EUR$7,950USD£6,013GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3902EUR$4,490USD£3,396GBP

The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition

 Report
June 2025
127 Pages
Global

From

€2564EUR$2,950USD£2,231GBP

Revenue Cycle Management Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4301EUR$4,949USD£3,743GBP

11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1086EUR$1,250USD£945GBP

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1086EUR$1,250USD£945GBP

Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1086EUR$1,250USD£945GBP

1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1086EUR$1,250USD£945GBP

Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
March 2024
267 Pages
Global

From

€6909EUR$7,950USD£6,013GBP

Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1086EUR$1,250USD£945GBP

1,136 Results (Page 48 of 57)
- 1
- 46
- 47
- 48
- 49
- 50

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.